Search

Your search keyword '"A. Hij"' showing total 291 results

Search Constraints

Start Over You searched for: Author "A. Hij" Remove constraint Author: "A. Hij"
291 results on '"A. Hij"'

Search Results

1. Spin-texture topology in curved circuits driven by spin-orbit interactions

2. MITOCHONDRIAL FRAGMENTATION IS A NEW THERAPEUTIC TARGET AND DIAGNOSTIC CRITERIA FOR MYELODYSPLASTIC SYNDROMES.

3. Morphology and Corrosion Behavior Study of Thin TiN Films Deposited at Different Substrates by DC Magnetron Sputtering

4. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

5. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

6. Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients

7. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

8. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)

10. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

12. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

14. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

15. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

16. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

17. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

18. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

21. Frequentie en acceptatie van door beslisondersteuning gegenereerde STOPP/START-signalen bij ouderen met polofarmacie en multimorbiditeit opgenomen in het ziekenhuis

22. Frequentie en acceptatie van door beslisondersteuning gegenereerde STOPP/START-signalen bij ouderen met polofarmacie en multimorbiditeit opgenomen in het ziekenhuis

23. DVT Management and Outcome Trends, 2001 to 2014

25. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

26. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

27. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud’s phEnomenon (SUNSHINE survey)

28. Conduite à tenir devant une thrombocytose de l’adulte

29. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

30. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

33. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

34. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis

36. Shock and Fright as Helicopters Swarm

37. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

38. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

39. [Diagnostic workup in front of an adult thrombocytosis]

40. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

41. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

42. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

43. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

44. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

45. Diagnostic workup in front of an adult thrombocytosis

46. Factors influencing patient’s perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study

47. Une thrombose veineuse profonde révélant une agénésie de la veine cave inférieure

48. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

49. Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis

50. [Rare sideroblastic anemias: about 2 cases, review of the literature and reminder of the main etiologies]

Catalog

Books, media, physical & digital resources